Alzheimer's Drug Discovery Foundation

Provides funding to leading scientists who are conducting the most promising, innovative Alzheimer’s drug research worldwide.

Be the first to review

Independent rating of Alzheimer's Drug Discovery Foundation VC fund

Overall rating:
Not reviewed

About Alzheimer's Drug Discovery Foundation VC fund

Founded:
1998

How Alzheimer's Drug Discovery Foundation VC fund invests

Rounds:
Grant, Series A, Venture Round, Funding Round
Average ticket size:
4.76M USD
Biggest investment:
24.3M USD
Would lead round:
Yes
Would coinvest:
Yes
Countries where invested:
United States
Sectors of interest:
Health Care, Biotechnology, Health Diagnostics, Therapeutics, Neuroscience, Medical Device, Medical, mHealth, Software, Pharmaceutical, Machine Learning, Life Science, Electronics, Clinical Trials, Augmented Reality

Portfolio - latest investments by Alzheimer's Drug Discovery Foundation VC fund
LEXEO Therapeutics
Altoida, Inc.
Biological Dynamics
Neuro Therapia
C2N Diagnostics
C. Light Technologies
NeuroVision Imaging
DiamiR
Vaccinex

Founders' reviews of Alzheimer's Drug Discovery Foundation VC fund

Be the first one to review Alzheimer's Drug Discovery Foundation.
Nobody reviews Alzheimer's Drug Discovery Foundation just yet. Help other founders navigate by writing about your experience with them.
Similar funds